FURIN and cystic fibrosis: We have previously demonstrated that BOS-318, a cell-permeable and highly selective potent inhibitor of furin robustly suppresses ENaC activity and improves airway surface hydration status and mucociliary transport (MCT) in a fully differentiated CF airway epithelial cell model [16].